C. Moreno et al., Abnormal pressure-natriuresis in hypertension: Role of cytochrome P450 metabolites of arachidonic acid, AM J HYPERT, 14(6), 2001, pp. 90S-97S
The pressure-natriuresis relationship is shifted to higher pressures in gen
etic and experimental models of hypertension; however, the factors responsi
ble for altering kidney function remain to be determined. In spontaneously
hypertensive (SHR) and Lyon hypertensive rats, the resetting of pressure-na
triuresis results from increased preglomerular renal vascular tone, whereas
sodium reabsorption is elevated in the thick ascending loop of Henle (TALH
) of Dahl S rats. Recently, a new route for the renal metabolism of arachid
onic acid (AA) has been described, and there is evidence that this pathway
contributes to the resetting of renal function in hypertension. In the kidn
ey, cytochrome P450 (CYP) enzymes metabolize AA primarily to 20-HETE and EE
Ts. 20-METE is a potent constrictor of renal arterioles that has an importa
nt role in autoregulation of renal blood flow and tubuloglomerular feedback
. 20-METE and EETS also inhibit sodium reabsorption in the proximal tubule
and TALH. In the SHR, the renal production of 20-METE is elevated and inhib
itors of the formation of 20-HETE decrease arterial pressure. Blockade of 2
0-HETE formation also reduces blood pressure or improves renal function in
deoxycorticosterone acetate (DOCA)-salt, angiotensin II-infused, and Lyon h
ypertensive rats. In contrast, 20-HETE formation is reduced in the TALH of
Dahl S rats and this contributes to elevated sodium reabsorption. Induction
of 20-METE synthesis improves pressure-natriuresis and lowers blood pressu
re in Dahl S rats, whereas inhibitors of the synthesis of 20-HETE promote t
he development of hypertension in Lewis rats. These findings indicate that
the renal production of CYP metabolites of AA is altered in genetic and exp
erimental models of hypertension and that this system contributes to the re
setting of pressure-natriuresis and the development of hypertension in some
models. Am J Hypertens 2001;14:90S-97S (C) 2001 American Journal of Hypert
ension, Ltd.